ARTHUR SELZER, M.D., F.A.C.P.; JOHN J. KELLY JR., M.D., F.A.C.P.; FRANK GERBODE, M.D.; WILLIAM J. KERTH, M.D.; JAMES E. BLACKLEY, M.D.; JOHN J. MORGAN, M.B., M.R.A.C.P.; K. KEYANI, M.D.
Atrial fibrillation, a common sequel to mitral valvular disease, profoundly affects the course of the disease. It adversely affects the performance of the heart; significant symptoms may first be produced by the onset of atrial fibrillation. Furthermore, it introduces the appreciable risk of systemic embolization. Consequently, the opportunity for the restoration of sinus rhythm after successful mitral valve surgery is considered one of the desirable goals of surgical treatment of the mitral valve. The purpose of this study is the determination of the effectiveness of treatment of atrial fibrillation after mitral valve surgery. A comparison between quinidine therapy and the
SELZER A, KELLY JJ, GERBODE F, KERTH WJ, BLACKLEY JE, MORGAN JJ, et al. Treatment of Atrial Fibrillation After Surgical Repair of the Mitral Valve. Ann Intern Med. ;62:1213–1222. doi: 10.7326/0003-4819-62-6-1213
Download citation file:
Published: Ann Intern Med. 1965;62(6):1213-1222.
Cardiology, Rhythm Disorders and Devices, Valvular Heart Disease.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use